Assembled from the company's filings and exchange data as of today. Download PDF renders this page on the server; the narrative sections arrive with the Nexa composer.
Dossier · PARAMOUNT COSMETICS (INDIA) LT · 9 October 2026Page 1 of 3
Company Dossier
MarketPing Research · factual · no rating expressed
PARAMOUNT COSMETICS (INDIA) LT
BSE: 507970
Fast Moving Consumer Goods › Fast Moving Consumer Goods › Personal Products › Personal Care

PARAMOUNT COSMETICS (INDIA) LT

StateQ4 FY26 filed
Last close · 8 Oct 2026₹37.47
Market cap₹0.0k cr
TTM P/E · P/B · EV/EBITDA17.6 · 0.89 · 7.8

Manufactures and sells personal care and cosmetic products to Indian consumers through a single Domestic Sales channel, which represented the entirety of reported segment revenue. FY26 total income was Rs 21.39 crore, with an EBITDA margin of 12.28% and net profit of Rs 0.05 crore. Operating costs break down as 10.4% employee costs, 11.2% other operating expenses and 2.2% depreciation as a share of revenue; the materials share is not separately quantified in the pack. The company has manufacturing and storage assets at Hosur, Tamil Nadu, and a property at Pardi, Gujarat. In February 2026 shareholders approved selling the Hosur land, building and plant & machinery to a related party, and selling the Gujarat property as part of business restructuring. Q4 FY26 revenue dropped sharply compared with a year earlier, and the company wrote off Rs 415.82 lakhs of inventory in FY26 due to spoilage, expiry and physical damage. Bank borrowings stand at Rs 8.53 crore with IDBI Bank, rated CARE B; Stable (long-term) and CARE A4 (short-term). AR · MarketPing reader · 2026-08-02

Revenue streams, as the annual report describes them. Domestic Sales (100%). Small, single-segment domestic personal care and cosmetics manufacturer with significant inventory shrink

What a broker report prints here — the analyst's thesis. This dossier prints the filed record instead; the narrative read of the latest results, the guidance ledger and the earnings-call summary are the composer's sections (INSTITUTIONAL-PLAN.md M3) and are not yet produced.

Exhibit 1: Financial summary, FY22–FY26 (all audited; no estimate years)

₹ crore · standaloneFY22FY23FY24FY25FY26
Revenue2027222021
EBITDA (ex other income)(1)3012
margin %(4.6)9.92.14.87.1
Owners' profit00000
EPS, as reported (₹)0.400.440.040.060.11
ROE % · ROCE %1.0 · 9.51.0 · 7.20.1 · 6.60.1 · 6.80.3 · 8.7
Debt / equity (x)0.660.620.600.560.12
Cash from operations14(0)111
Capex(0)(0)(0)(0)(0)
Source: SEBI results XBRL as filed with BSE/NSE; EBITDA excludes other income.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · PARAMOUNT COSMETICS (INDIA) LT · 9 October 2026Page 2 of 3

Exhibit 2: Quarterly performance, last 8 quarters

₹ croreQ1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26
Revenue45665953
Profit before tax000(0)0000
Net profit000(0)(0)00(0)
EPS (₹)0.110.110.170.150.500.950.280.40
Source: quarterly results as filed; the balance sheet is filed half-yearly and is not repeated here.

Exhibit 3: Peers — basic industry group, by market cap

CompanyM.cap ₹ crP/EP/BEV/EBITDAROE %ROCE %Rev CAGR 5y %EBITDA m. %
GODREJ CONSUMER PRODUCTS88,50746.26.9928.714.719.06.619.8
DABUR INDIA LTD66,84433.95.6622.315.819.86.624.3
CUPID LIMITED47,971131.2106.41318.224.030.3—40.3
COLGATE PALMOLIVE LTD.47,21135.029.80—83.7107.1—31.3
GILLETTE INDIA LTD23,75835.625.10—69.183.4—29.8
P&G HYGIENE & HEALTH CARE22,04727.929.26—113.7134.4—20.1
EMAMI LIMITED16,02021.45.4815.426.528.45.623.5
HONASA CONSUMER LIMITED15,24952.610.8048.014.216.9—17.6
Source: exchange data and filed statements via the screener; multiples at current prices.

Exhibit 4: Where the company sits in its group

MetricCompanyGroup medianRankBetter than
P/E (TTM)17.635.61 of 15100%
P/B0.98.12 of 1392%
ROCE1.319.413 of 1620%
ROE0.315.811 of 1317%
Debt / Equity0.10.012 of 138%
EBITDA margin26.823.55 of 1367%
Revenue growth(53.3)13.413 of 148%
Profit growth(167.8)9.413 of 130%
Market cap181082516 of 160%
Source: MarketPing peer ranks; a rank is a measurement, not a view.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · PARAMOUNT COSMETICS (INDIA) LT · 9 October 2026Page 3 of 3

Exhibit 5: Filings of the last 90 days, with the measured price reaction

Date · filingCategoryImportance1-day %5-day %
7 Oct 2026 · Board to consider fund raising via QIP, rights issue, and other modesfund raisingmedium——
6 Oct 2026 · Notice of 1st EGM for FY 2026-27 published in newspaperscomplianceminimal——
6 Oct 2026 · Newspaper notice of 1st EGM for FY 2026-27; e-voting from Oct 26 to 28complianceminimal——
6 Oct 2026 · RTA submits quarterly demat compliance certificate to BSEcomplianceminimal——
5 Oct 2026 · Paramount Cosmetics EGM on October 29 to hike authorized share capitalboard shareholder meetingslow——
2 Oct 2026 · AGM 2026 Voting Results: All 3 Resolutions Passedboard shareholder meetingslow——
2 Oct 2026 · 41st AGM voting results: all 3 resolutions passed with 99.99% majorityboard shareholder meetingslow——
30 Sept 2026 · Paramount Cosmetics 41st AGM concludes; RPT with Paramount Kum Kum approvedboard shareholder meetingslow——
29 Sept 2026 · Board approves hike in authorized share capital to Rs 39 crorecorporate actionshigh——
29 Sept 2026 · Board approves increase in Authorised Share Capital to Rs. 39 crorecorporate actionsmedium——
Source: exchange announcements; reaction = close-to-close from the filing's session.

How to read this document

Where a broker report showsThis document showsWhy
A rating (BUY / ADD / REDUCE / SELL)A state: the latest filed quarter and the measured reactionsan event is a fact; a rating is an opinion that requires SEBI RA registration
A target price and upsideThe current price and the multiples against the groupa target is a forecast; a multiple is a measurement
Estimate years marked EMore audited years; no estimatesMarketPing publishes no forecasts — your own model lives on the Models page

Sources, method and disclosures

This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.

Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in